在一名手术无法治疗的患者中，通过房间隔缺损封堵术同时经股动脉进行经导管二尖瓣和三尖瓣缘对缘修复（使用MitraClip系统）。首例人体报告。
Simultaneous transfemoral transcatheter mitral and tricuspid valve edge-to-edge repair (using MitraClip system) completed by atrial septal defect occlusion in a surgically inoperable patient. First-in-human report.
作者信息
Kowalski Marek, Franz Norbert, Ritter Frank, Hofmann Steffen, Stabel-Mahassine Chourok, Warnecke Henning, Thale Joachim
机构信息
Department of Cardiology, Schuechtermann-Klinik, Bad Rothenfelde, Germany.
Department of Cardiology, Schuechtermann-Klinik, Bad Rothenfelde, Germany; University Witten/Herdecke, Germany.
出版信息
Kardiochir Torakochirurgia Pol. 2015 Dec;12(4):295-7. doi: 10.5114/kitp.2015.56776. Epub 2015 Dec 30.
Transcatheter transfemoral mitral valve repair using the MitraClip system (Abbott Vascular, USA) is used in high-risk or inoperable patients with severe mitral regurgitation. We report the first-in-human simultaneous transfemoral clipping of the mitral and tricuspid valve completed by occlusion of an atrial septal defect (ASD). The procedure was performed in an 84-year-old patient in October 2015. After effective reduction of mitral and tricuspid regurgitations using the MitraClip system a PFO Occluder (St. Jude Medical, USA) was implanted. Transfemoral simultaneous mitral and tricuspid valve repair using the MitraClip system with ASD occlusion seems to be an effective therapy for high-risk or inoperable patients.
使用MitraClip系统（美国雅培血管公司）经导管经股动脉二尖瓣修复术用于治疗重度二尖瓣反流的高危或无法手术的患者。我们报告了首例通过封堵房间隔缺损（ASD）完成经股动脉同时夹闭二尖瓣和三尖瓣的人体手术。该手术于2015年10月在一名84岁患者身上进行。使用MitraClip系统有效减少二尖瓣和三尖瓣反流后，植入了一个PFO封堵器（美国圣犹达医疗公司）。使用MitraClip系统并封堵ASD经股动脉同时进行二尖瓣和三尖瓣修复术似乎是治疗高危或无法手术患者的有效方法。
Zotero 插件